Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors

for
Solid Tumor
Location: Grand Rapids MI, Dallas TX, San Antonio TX
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07703878

Phase 1, Recruiting

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

for
Advanced Solid Tumors
Location: Grand Rapids MI, San Antonio TX, West Valley City UT
Sponsor: ModernaTX, Inc.

Sex: All

Age: 18+

Code: NCT06880549

Phase 1, Recruiting

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery

for
Breast Cancer
Location: Philadelphia PA, Montreal
Sponsor: University Hospital, Basel, Switzerland

Sex: All

Age: 18+

Code: NCT07140172

Recruiting

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

for
Diffuse Intrinsic Pontine Glioma, DIPG, Brain Tumor, CNS Tumor,
Location: Philadelphia PA, Atlanta GA, Chicago IL, Seattle WA
Sponsor: BrainChild Bio, Inc

Sex: All

Age: 1 - 26

Code: NCT07680439

Phase 2, Recruiting

Rash & Diarrhea Prophylaxis With Capivasertib

for
Metastatic HR+/HER2- Breast Cancer
Location: New Haven CT
Sponsor: Maryam Lustberg

Sex: All

Age: 18+

Code: NCT07426822

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Orange City FL, Clermont FL, Detroit MI, Louisville KY,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT04198766

Phase 1, Phase 2, Recruiting

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Lake Success NY, Buffalo NY, Sarasota FL,
Sponsor: InduPro, Inc.

Sex: All

Age: 18+

Code: NCT07602842

Phase 1, Phase 2, Recruiting

Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams

for
Malignant Solid Neoplasm
Location: Danville IL, Urbana IL, Mattoon IL, Effingham IL,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07278739

Recruiting

Planning Grant for TOPS for Breast Cancer Survivors

for
Breast Cancer, Weight Loss
Location: Durham NC
Sponsor: Duke University

Sex: Female

Age: 21 - 70+

Code: NCT06658912

Recruiting

SLR-108 PET Imaging in Subjects With Advanced Cancer

for
Metastatic Solid Tumors
Location: Newport Beach CA
Sponsor: Solve Therapeutics

Sex: All

Age: 18+

Code: NCT07728942

Phase 1, Recruiting

Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC

for
Breast Cancer Recurrent
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT05464082

Phase 2, Recruiting

A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab

for
Advanced Solid Cancer, Metastatic Solid Cancer
Location: New Haven CT, Hackensack NJ, Nashville TN
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07607678

Phase 1, Recruiting

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

for
Solid Tumor, Adult
Location: Boston MA, New Haven CT, Pittsburgh PA, Orlando FL,
Sponsor: Ribon Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04053673

Phase 1, Recruiting

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

for
Breast Cancer
Location: New York NY, Baltimore MD, Fairfax VA, Miami FL,
Sponsor: Proton Collaborative Group

Sex: Female

Age: 19+

Code: NCT05856773

Phase 3, Recruiting

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

for
Early Breast Cancer
Location: Norwich CT, Albany NY, East Brunswick NJ,
Sponsor: Genentech, Inc.

Sex: Female

Age: 18+

Code: NCT07541079

Phase 3, Recruiting

Adherence Intervention in Patients With Metastatic Breast Cancer

for
Breast Cancer
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 18 - 70+

Code: NCT06121453

Recruiting

Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD

for
Breast Cancer, Leptomeningeal Disease
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT07694986

Phase 2, Recruiting

Breast Elasticity Imaging During Neoadjuvant Chemotherapy

for
Breast Cancer
Location: New York NY
Sponsor: Columbia University

Sex: Female

Age: 18+

Code: NCT04824027

Recruiting

Access My Breast Cancer Care App

for
Breast Reconstruction, Breast Cancer
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 19+

Code: NCT07696637

Recruiting

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

for
ER-Positive HER2-Negative Breast Cancer
Location: Marietta GA, Edgewood KY, Kingwood TX, Fort Worth TX
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07647328

Phase 3, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial